Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Final Guidance Names Submissions Subject To ClinicalTrials.gov Certification

This article was originally published in The Gray Sheet

Executive Summary

Final guidance published Jan. 21 provides answers for device companies still confused about how and when they must certify to FDA that they have registered their clinical trials on ClinicalTrials.gov

You may also be interested in...



Adverse Event Reports: Posting On ClinicalTrials.gov Begins Soon

Device and drug firms must begin posting serious and frequent adverse event data from certain clinical trials on the National Institutes of Health's ClinicalTrials.gov database by September, NIH confirmed April 20

Adverse Event Reports: Posting On ClinicalTrials.gov Begins Soon

Device and drug firms must begin posting serious and frequent adverse event data from certain clinical trials on the National Institutes of Health's ClinicalTrials.gov database by September, NIH confirmed April 20

Managing The Minefield Of Mandatory Clinical Trial Registration

As key portions of the government's new device clinical trial registry requirements went into effect last week, Medtronic clinical research director Lisa Griffin Vincent offered advice on complying with some of the thornier aspects of the law

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT027031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel